US Stock MarketDetailed Quotes

RVPHW REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM)

Watchlist

0.2980
+0.0680+29.57%

Close May 31 16:00 ET

0Market Cap0.00P/E (TTM)

REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

13.42%7.92M

39.94%39.5M

-14.60%9.99M

200.57%10.71M

118.69%12.07M

-6.25%6.98M

179.37%28.23M

195.01%11.7M

43.85%3.56M

208.33%5.52M

Selling and administrative expenses

42.50%2.14M

50.85%8.08M

2.42%1.51M

58.46%1.99M

206.37%3.08M

-7.38%1.5M

2.01%5.36M

13.41%1.48M

19.32%1.26M

-29.01%1.01M

-General and administrative expense

42.50%2.14M

50.85%8.08M

2.42%1.51M

58.46%1.99M

206.37%3.08M

-7.38%1.5M

2.01%5.36M

13.41%1.48M

19.32%1.26M

-29.01%1.01M

Research and development costs

5.47%5.78M

37.38%31.42M

-17.06%8.48M

278.03%8.72M

99.17%8.99M

-5.93%5.48M

371.39%22.87M

283.80%10.22M

62.01%2.31M

1,105.99%4.51M

Operating profit

-13.42%-7.92M

-39.94%-39.5M

14.60%-9.99M

-200.57%-10.71M

-118.69%-12.07M

6.25%-6.98M

-179.37%-28.23M

-195.01%-11.7M

-43.85%-3.56M

-208.33%-5.52M

Net non-operating interest income expense

21.71%169.61K

172.95%498.96K

55.60%177.52K

61.55%85.86K

553.32%90.32K

7,932.05%139.36K

7,672.58%182.8K

7,337.55%114.09K

9,816.64%53.15K

489.55%13.83K

Non-operating interest income

17.74%173.1K

172.95%498.96K

37.70%157.11K

72.65%91.76K

645.61%103.08K

8,373.26%147.01K

--182.8K

--114.09K

--53.15K

--13.83K

Non-operating interest expense

-54.45%3.49K

----

--5.9K

--12.76K

--7.66K

----

--0

Other net income (expense)

9,787.74%326.28K

-22.86%-239.22K

118.22%81.98K

4,062.46%144.27K

-365.42%-456.2K

-103.87%-3.37K

-112.24%-194.71K

-261.78%-449.99K

-101.82%-3.64K

-9.13%171.88K

Gain on sale of security

4,000.10%456.18K

-22.86%-239.22K

114.46%66.76K

--139.08K

-356.25%-456.18K

-87.50%11.13K

-112.24%-194.71K

-266.00%-461.74K

----

-5.88%178.02K

Other non- operating income (expenses)

-796.19%-129.89K

----

242.65%5.19K

99.69%-19

-636.86%-14.49K

----

---3.64K

---6.14K

Income before tax

-8.43%-7.43M

-38.96%-39.24M

19.14%-9.73M

-198.25%-10.48M

-133.16%-12.44M

6.96%-6.85M

-231.62%-28.24M

-226.52%-12.03M

-54.29%-3.51M

-232.43%-5.33M

Income tax

148.35%7.4K

-18.42%16.95K

-154.79%-4.58K

550.05%12.12K

-7.01%6.44K

-17.94%2.98K

246.05%20.78K

8.36K

-11.32%1.86K

77.37%6.92K

Net income

-8.49%-7.43M

-38.92%-39.26M

19.24%-9.72M

-198.44%-10.49M

-132.98%-12.44M

6.97%-6.85M

-231.63%-28.26M

-226.75%-12.04M

-54.23%-3.52M

-232.05%-5.34M

Net income continuous Operations

-8.49%-7.43M

-38.92%-39.26M

19.24%-9.72M

-198.44%-10.49M

-132.98%-12.44M

6.97%-6.85M

-231.63%-28.26M

-226.75%-12.04M

-54.23%-3.52M

-232.05%-5.34M

Minority interest income

Net income attributable to the parent company

-8.49%-7.43M

-38.92%-39.26M

19.24%-9.72M

-198.44%-10.49M

-132.98%-12.44M

6.97%-6.85M

-231.63%-28.26M

-226.75%-12.04M

-54.23%-3.52M

-232.05%-5.34M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-8.49%-7.43M

-38.92%-39.26M

19.24%-9.72M

-198.44%-10.49M

-132.98%-12.44M

6.97%-6.85M

-231.63%-28.26M

-226.75%-12.04M

-54.23%-3.52M

-232.05%-5.34M

Basic earnings per share

Diluted earnings per share

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	13.42%7.92M	39.94%39.5M	-14.60%9.99M	200.57%10.71M	118.69%12.07M	-6.25%6.98M	179.37%28.23M	195.01%11.7M	43.85%3.56M	208.33%5.52M
Selling and administrative expenses	42.50%2.14M	50.85%8.08M	2.42%1.51M	58.46%1.99M	206.37%3.08M	-7.38%1.5M	2.01%5.36M	13.41%1.48M	19.32%1.26M	-29.01%1.01M
-General and administrative expense	42.50%2.14M	50.85%8.08M	2.42%1.51M	58.46%1.99M	206.37%3.08M	-7.38%1.5M	2.01%5.36M	13.41%1.48M	19.32%1.26M	-29.01%1.01M
Research and development costs	5.47%5.78M	37.38%31.42M	-17.06%8.48M	278.03%8.72M	99.17%8.99M	-5.93%5.48M	371.39%22.87M	283.80%10.22M	62.01%2.31M	1,105.99%4.51M
Operating profit	-13.42%-7.92M	-39.94%-39.5M	14.60%-9.99M	-200.57%-10.71M	-118.69%-12.07M	6.25%-6.98M	-179.37%-28.23M	-195.01%-11.7M	-43.85%-3.56M	-208.33%-5.52M
Net non-operating interest income expense	21.71%169.61K	172.95%498.96K	55.60%177.52K	61.55%85.86K	553.32%90.32K	7,932.05%139.36K	7,672.58%182.8K	7,337.55%114.09K	9,816.64%53.15K	489.55%13.83K
Non-operating interest income	17.74%173.1K	172.95%498.96K	37.70%157.11K	72.65%91.76K	645.61%103.08K	8,373.26%147.01K	--182.8K	--114.09K	--53.15K	--13.83K
Non-operating interest expense	-54.45%3.49K	----	----	--5.9K	--12.76K	--7.66K	----	----	--0	--0
Other net income (expense)	9,787.74%326.28K	-22.86%-239.22K	118.22%81.98K	4,062.46%144.27K	-365.42%-456.2K	-103.87%-3.37K	-112.24%-194.71K	-261.78%-449.99K	-101.82%-3.64K	-9.13%171.88K
Gain on sale of security	4,000.10%456.18K	-22.86%-239.22K	114.46%66.76K	--139.08K	-356.25%-456.18K	-87.50%11.13K	-112.24%-194.71K	-266.00%-461.74K	----	-5.88%178.02K
Other non- operating income (expenses)	-796.19%-129.89K	----	----	242.65%5.19K	99.69%-19	-636.86%-14.49K	----	----	---3.64K	---6.14K
Income before tax	-8.43%-7.43M	-38.96%-39.24M	19.14%-9.73M	-198.25%-10.48M	-133.16%-12.44M	6.96%-6.85M	-231.62%-28.24M	-226.52%-12.03M	-54.29%-3.51M	-232.43%-5.33M
Income tax	148.35%7.4K	-18.42%16.95K	-154.79%-4.58K	550.05%12.12K	-7.01%6.44K	-17.94%2.98K	246.05%20.78K	8.36K	-11.32%1.86K	77.37%6.92K
Net income	-8.49%-7.43M	-38.92%-39.26M	19.24%-9.72M	-198.44%-10.49M	-132.98%-12.44M	6.97%-6.85M	-231.63%-28.26M	-226.75%-12.04M	-54.23%-3.52M	-232.05%-5.34M
Net income continuous Operations	-8.49%-7.43M	-38.92%-39.26M	19.24%-9.72M	-198.44%-10.49M	-132.98%-12.44M	6.97%-6.85M	-231.63%-28.26M	-226.75%-12.04M	-54.23%-3.52M	-232.05%-5.34M
Minority interest income
Net income attributable to the parent company	-8.49%-7.43M	-38.92%-39.26M	19.24%-9.72M	-198.44%-10.49M	-132.98%-12.44M	6.97%-6.85M	-231.63%-28.26M	-226.75%-12.04M	-54.23%-3.52M	-232.05%-5.34M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-8.49%-7.43M	-38.92%-39.26M	19.24%-9.72M	-198.44%-10.49M	-132.98%-12.44M	6.97%-6.85M	-231.63%-28.26M	-226.75%-12.04M	-54.23%-3.52M	-232.05%-5.34M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall